The acute national shortages affecting several presentations of intravenous (IV) fluids that started in 2024 have resolved and overall supply is stable.
As the supply of IV fluids has stabilised, use by health facilities can return to normal. However, ongoing careful and responsible use of IV fluids is encouraged to support sustainable supply.
